CT

Cancer Treatment Reviews

Cancer Treatment Reviews is an international journal that provides state of the art, authoritative review articles to the clinician and researcher to keep them abreast of modern concepts and the latest developments in cancer treatment research.

Looking to publish in Cancer Treatment Reviews? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Try Livewrite Now
Subject Oncology
Impact Factor 10.5
Quartile Q1
Open Access Type Hybrid
ISSN 0305-7372
eISSN 1532-1967
Invitation Only No
Cost Range Article publishing charge applies for open access articles; amount not specified.

Submission Instructions

Cancer Treatment Reviews accepts the following article types. Click on an article type to view submission instructions.

Tumour Review

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract must not exceed 250 words.
Manuscript Manuscript must not exceed 5000 words, excluding tables and figures. Manuscript must be divided into clearly defined sections using headings. Submission must include 1 to 7 keywords in English and article highlights provided as a separate editable file containing 3 to 5 bullet points of no more than 85 characters each, and images created or altered using generative AI or AI-assisted tools are not permitted.
References A maximum of 100 references is recommended, with exceptions subject to editorial approval. References must use a numbered square-bracket citation style. Reference list must be numbered in the order of first appearance in the text, journal names must be abbreviated according to the List of Title Word Abbreviations, and references with more than 6 authors must list the first 6 followed by 'et al.'.
Figures & Tables Manuscript is limited to 6 figures and/or tables. Figures must be uploaded as separate files, while tables must be submitted as editable text. All figures and tables must be cited in the text, numbered consecutively in order of appearance, and accompanied by captions.
Reformat to Cancer Treatment Reviews using Livewrite Premium

Systematic Or Meta-Analysis Studies

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract must not exceed 250 words.
Manuscript Manuscript must not exceed 5000 words excluding tables and figures. Manuscript must be divided into clearly defined sections using headings. Submission must include 1 to 7 English keywords and article highlights provided as a separate editable file containing 3 to 5 bullet points of no more than 85 characters each.
References A maximum of 100 references is recommended, with exceptions subject to editorial approval. References must be cited by number in square brackets. Reference list must be numbered in the order of appearance in the text, include the required bibliographic details, use abbreviated journal names, and list the first 6 authors followed by 'et al.' when there are more than 6 authors.
Figures & Tables A maximum of 6 figures and/or tables is allowed. Figures must be uploaded as separate files, while tables must be submitted as editable text. All figures and tables must be cited in the text, numbered consecutively, and provided with captions.
Reformat to Cancer Treatment Reviews using Livewrite Premium

Recent Publications

Re-challenge strategies in neuroendocrine tumours: adding another arrow in the quiver?

Lavinia Benini, Davide Ciardiello, Francesca Spada, Chiara Alessandra Cella, Lorenzo Gervaso, Cristiana Mulargiu, Maria Giulia Zampino, Nicola Fazio

10.1016/j.ctrv.2026.103171
View Publication

Editorial Board

-

10.1016/s0305-7372(26)00081-2
View Publication

The antibiotic-immunotherapy interaction in NSCLC: a systematic review and meta-analysis of 54,250 patients across three outcomes

Dimitrios Stylianakis, Valentina Bertaglia, Dario Sangiolo, Mauro Podda, Giorgio Saba, Ioannis Stylianakis, Nerina Denaro, Adolfo Pisanu, Sofia Agelaki, Mario Scartozzi, Silvia Novello, Cinzia Solinas

10.1016/j.ctrv.2026.103162
View Publication

Progress toward personalized management of stage II/III triple negative breast cancer

Irene Valle, Joana M Ribeiro, Thomas Grinda, Marleen Kok, Barbara Pistilli, Gustavo Werutsky, Elie Rassy

10.1016/j.ctrv.2026.103143
View Publication

The role of the 21-gene assay in the neoadjuvant setting for hormone receptor-positive HER2-negative breast cancer: Impact on systemic and surgical treatment decisions

Á.Guerrero Zotano, T.M. Allweis, R. Foerster, C. Palmieri, O. Gluz, S. Chia, C. Sotiriou, G. Bianchini

10.1016/j.ctrv.2026.103161
View Publication

Frequently asked questions

How long does it take to publish?

Median 4 days from submission to first decision.

Reformat to Cancer Treatment Reviews using Livewrite Premium

What are the publication costs?

Article publishing charge applies for open access articles; amount not specified.

Reformat to Cancer Treatment Reviews using Livewrite Premium

Research Topics

Cancer Treatment and Pharmacology Human auditory perception and evaluation Diverse Scientific and Economic Studies Lung Cancer Treatments and Mutations HER2/EGFR in Cancer Research Educational Robotics and Engineering Breast Cancer Treatment Studies Lung Cancer Research Studies Cancer Immunotherapy and Biomarkers Colorectal Cancer Treatments and Studies Cancer Genomics and Diagnostics Bone health and treatments Neuroendocrine Tumor Research Advances Cancer therapeutics and mechanisms Lymphoma Diagnosis and Treatment Prostate Cancer Treatment and Research Pancreatic and Hepatic Oncology Research Estrogen and related hormone effects Radiopharmaceutical Chemistry and Applications Immunotherapy and Immune Responses CAR-T cell therapy research Advanced Breast Cancer Therapies Ovarian cancer diagnosis and treatment Renal cell carcinoma treatment Chronic Lymphocytic Leukemia Research

Related Journals

AR
Annual Review of Cancer Biology ANNUAL REVIEWS
MI
Medical Image Analysis Elsevier BV
HR
Hearing Research Elsevier BV
Ga
Gastroenterology Elsevier BV
AJ
American Journal of Obstetrics & Gynecology MFM Elsevier BV
CD
Current Developments in Nutrition Elsevier BV